The purpose of the International Registry for Drug-Induced Arrhythmias is to learn from cases of drug-induced arrhythmia now so that we can prevent future cases. If you know a patient suspected of having arrhythmias or cardiac arrest due to a drug or drug combination we would like to hear about them. The Registry is not intended for patients with congenital Long QT Syndrome (LQTS) unless the patients have developed arrhythmias directly associated with and, thought to be precipitated by, a drug or drug combination.
- Collect data on the prevalence of drug-induced LQTS.
- Review 12-lead ECGs of patients using new techniques.
- Obtain blood, buccal cells, or tissue for genetic analysis.
- To discover all risk factors for Torsades de Pointes.
- To develop a test to rapidly predict individuals at risk of drug-induced arrhythmias.
- A quarterly University of Arizona CERT email or fax newsletter with information garnered from our International Registry for Drug-Induced Arrhythmias and the medical literature.
- Telephone or e-mail consultation on your cases.
- Regularly updated reference cards on acquired LQTS and drug interactions.
- Anonymous reporting of cases to the FDA MedWatch Program.
The University of Arizona Center for Education and Research on Therapeutics
Arizona Health Sciences Center
Tucson, Arizona 85724-5018
Funded in part by Agency for Healthcare Research and Quality grant 1 U18 HS10385-01
Disclaimer and Waiver
The information presented is intended solely for the purpose of providing general information about health related matters. It is not intended for any other purpose, including, but not limited to, medical or pharmaceutical advice and/or treatment, nor is it intended to substitute for the users' relationships with their own health care/pharmaceutical providers. To that extent, by continued use of this program, the user affirms the understanding of the purpose and releases the University of Arizona, State of Arizona and Arizona Board of Regents from any claims arising out of his/her use of the website.